Skip to main content

Table 1 DMRs overlapping DAMEs

From: DAMEfinder: a method to detect differential allele-specific methylation

  DMR state Total DMRs DMRs with DAMEs DAMEs with DMRs Gain/loss ASM
CIMP Hyper 5040 2171 2789 2694/95
Hypo 1713 114 116 88/28
Non-CIMP Hyper 3187 76 77 61/16
Hypo 10,033 88 88 64/24
  1. Hyper- or hypo-methylated DMR refers to the increase or decrease of methylation in cancers in comparison with paired normal samples, while gain or loss of ASM refers to whether cancers have more or less allele specificity than paired normal samples